United States : ASTELLAS needs US FDA approval for tacrolimus ER capsules ... Equities.com As per the reports, Astellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tacrolimus extended release capsules for the ... |